ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 2,455.00
-30.00 (-1.21%)
At close: Nov 13, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 224.39 billion as of November 13, 2026. It is the 21,633rd most valuable company in the world and the 742nd biggest in South Korea. Its market cap has decreased by 47.11% in one year.
Market Cap
224.39B
Enterprise Value
131.26B
Revenue
n/a
Global Rank
Country Rank
#742 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 224.39B, a decrease of -59.02%. That is a compound annual growth rate of -45.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 224.39B | -76.76% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 180.49B |
| DAE HWA Pharmaceutical | 170.22B |
| HEM Pharma | 168.69B |
| GC WellBeing | 167.71B |
| CellBion | 153.31B |
| NOVAREX | 151.38B |
| Kyung Dong Pharmaceutical | 144.45B |
| PHARMARESEARCH BIO | 117.48B |